# Posaconazole to Treat Invasive Fungal Infections

> **NCT00033982** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (—)

## Conditions studied

- Granulomatous Disease, Chronic
- Job's Syndrome
- Infection

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT00033982
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04-11
- **Primary completion:** —
- **Final completion:** 2007-02-20
- **Target enrollment:** 50 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033982, "Posaconazole to Treat Invasive Fungal Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00033982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*